Koers Nutralife Biosciences Inc Other OTC
Aandelen
US67091B1044
Farmaceutische producten
Omzet 2020 | 1,26 mln. 1,17 mln. | Omzet 2021 | 627K 582K | Marktkapitalisatie | 13,01 mln. 12,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -2 mln. -1,86 mln. | Nettowinst (verlies) 2021 | -5 mln. -4,64 mln. | EV/omzet 2020 | 14,5 x |
Nettoschuld 2020 | 3,16 mln. 2,93 mln. | Nettoschuld 2021 | 3,01 mln. 2,79 mln. | EV/omzet 2021 | 25,6 x |
K/w-verhouding 2020 |
-4,81
x | K/w-verhouding 2021 |
-2,18
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 54,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edgar Ward
FOU | Founder | 52 | 01-04-10 |
Nicholas Ward
COO | Chief Operating Officer | - | 01-04-10 |
Nicole Archon
AUD | Comptroller/Controller/Auditor | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edgar Ward
FOU | Founder | 52 | 01-04-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |